Cetirizine Hydrochloride
NDC 45802-626, Cetirizine hydrochloride, solution, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-626
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078398
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE1 mg/mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-626-26 | 45802062626 | 1 BOTTLE in 1 CARTON (45802-626-26) / 120 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2f47dbc5-dfb4-425c-9fe4-777fa3c4e72eNADAC price for package 45802062626
GET /v1/drugs/nadac/45802062626
Use it
Look up 45802-626 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.